Antitauon Today

Promoting the removal of pathological tau via microglia or through intracellular degradation pathways like the proteasome. Key Therapeutic Strategies

Current research focuses on both to combat these tauon species: Example Agents / Trials Passive Immunotherapy antitauon

Stopping tau proteins from sticking together to form toxic seeds. Promoting the removal of pathological tau via microglia

Using antibodies to bind to extracellular tau species, preventing them from being taken up by healthy neighboring neurons. The concept of "tauons" arises from the observation

The concept of "tauons" arises from the observation that misfolded tau protein isoforms can propagate through the brain in a characteristic pattern, similar to prions, driving the progression of conditions like Alzheimer's disease. Antitauon therapies aim to intervene in this process through several key mechanisms:

In the context of neurodegenerative research, "antitauons" refer to or therapeutic agents designed to neutralize tauons —the prion-like, pathological forms of the tau protein that spread from neuron to neuron. Overview of Tauons and Antitauons